Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-01-02 @ 9:33 PM
Study NCT ID:
NCT04189094
Status:
UNKNOWN
Last Update Posted:
2019-12-06
First Post:
2019-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC
Sponsor:
Zhejiang Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-27
First Submit QC Date:
None
Study First Post Date:
2019-12-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-04
Last Update Post Date:
2019-12-06
Last Update Post Date Type:
ACTUAL